Abstract
Introduction:
Cystic fibrosis (CF) is a hereditary autosomal recessive disease driven by deleterious variants of the CFTR gene, leading, among other symptoms, to increased lung infection susceptibility. Mucus accumulation in the CF lung is, as of yet, considered as one important factor contributing to its colonization by opportunistic pathogens such as Pseudomonas aeruginosa. However, in recent years evidence was provided that alveolar macrophages, which form the first line of defense against airborne pathogens, seem to be intrinsically defective with regard to bactericidal functionality in the CF lung. To assess the impact of CFTR deficiency in human macrophages only insufficient systems are available.
Methods:
To address this problem and to evaluate the role of CFTR in human macrophages, we successfully differentiated human induced pluripotent stem cells (iPSC) from a CF p.Phe508del homozygous individual and a healthy donor into primitive macrophages (iMacΔF508 and iMacWT), respectively, and compared the bactericidal functionality in the relevant cell type.
Results:
iMacΔF508 showed impaired P. aeruginosa clearance and intracellular killing capacity in comparison to iMacWT. Furthermore, iMacΔF508 exhibited a less acidic lysosomal pH, and upon P. aeruginosa infection, there were signs of mitochondrial fragmentation and autophagosome formation together with a hyperinflammatory phenotype and deficient type I interferon response.
Conclusion:
In summary, we present a defective phenotype in iMacΔF508 upon P. aeruginosa infection, which will constitute an ideal platform to further study the role of macrophages in the context of CF.
Keywords:
Pseudomonas aeruginosa; cystic fibrosis; iPSC; infection; lung immunity; macrophages.
Copyright © 2024 Rodriguez Gonzalez, Basílio-Queirós, Neehus, Merkert, Tschritter, Ünal, Hegermann, Mörgelin, Bustamante, Nietert, Martin, Tümmler, Munder and Lachmann.
MeSH terms
-
Cell Differentiation / genetics
-
Cells, Cultured
-
Cystic Fibrosis Transmembrane Conductance Regulator* / deficiency
-
Cystic Fibrosis Transmembrane Conductance Regulator* / genetics
-
Cystic Fibrosis* / genetics
-
Cystic Fibrosis* / immunology
-
Cystic Fibrosis* / microbiology
-
Humans
-
Induced Pluripotent Stem Cells* / metabolism
-
Macrophages / immunology
-
Macrophages / metabolism
-
Macrophages / microbiology
-
Pseudomonas Infections* / genetics
-
Pseudomonas Infections* / immunology
-
Pseudomonas aeruginosa* / immunology
-
Pseudomonas aeruginosa* / physiology
-
Transcriptome*
Substances
-
Cystic Fibrosis Transmembrane Conductance Regulator
-
CFTR protein, human
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was made possible by a non-clinical research grant from the Mukoviszidose e.V. to AM and NL (project number 1905). Additional funding was provided by the German Center of Lung Research (DZL) to AM. This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No. 852178) (grant agreement No. 101100859 “iPYRO” and No. 101158172 “iMAClung). The work is also funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy -EXC 2155 -project number 390874280 and REBIRTH Research Center for Translational Regenerative Medicine “Förderung aus Mitteln des Niedersächsischen Vorab” (grant: ZN3340). The work is also funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) LA 3680/9-1. A-LN was supported by the international PhD program of the Imagine Institute, the Bettencourt-Schueller Foundation, the fin de thèse program of the FRM (FDT202204015102) and the EMBO Postdoctoral Fellowship (ALTF 209-2024). MN was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) project number 315063128.